16 nominees · 8 ballot items.
Election of 14 Equity directors; Ratification of Ernst & Young LLP as independent auditors; Advisory vote to approve executive compensation; Amendments to certificate of incorporation to eliminate Class B-1, B-2, and B-3 director election rights and related inoperative provisions; Election of Class B-1 (3), Class B-2 (1) and Class B-3 (1) directors.
Elect 14 Equity directors to serve until the 2027 annual meeting.
Ratify the board-appointed Ernst & Young LLP as CME Group’s independent registered public accounting firm for 2026.
The proposal asks shareholders to ratify the audit committee’s selection of Ernst & Young LLP as the company’s independent registered public accounting firm for 2026. Management seeks this advisory ratification as good governance practice though shareholder approval is not required; the audit committee retains the discretion to change auditors regardless of the vote. The filing emphasizes benefits of continuity — EY’s long tenure since 2002 provides deep institutional knowledge of CME Group’s complex global operations, accounting policies and internal controls — and cost advantages from existing efficiencies. The audit committee’s review focused on audit quality, independence, EY’s technical resources and global capabilities, historical performance and PCAOB inspection data. The company discloses audit and non-audit fees and its pre-approval processes designed to protect auditor independence. A “FOR” vote aligns investors with the audit committee’s assessment that EY remains qualified and that continuity supports audit quality; a vote against would signal investor concerns and could trigger the audit committee to reconsider the engagement. Risks to investors include perceived audit tenure concentration, which the proxy addresses via lead partner rotation and committee oversight.
Non-binding advisory vote to approve the compensation of the named executive officers as disclosed in the proxy statement.
This non-binding advisory proposal asks shareholders to approve CME Group’s 2025 executive compensation as disclosed in the proxy. Management positions the program as pay-for-performance with at least 50% of NEO target compensation performance-based, using cash-earnings-funded bonuses, performance shares tied to TSR and absolute net income margin, and time-vested restricted stock. The compensation committee engaged an independent consultant, considered shareholder feedback and implemented design changes (e.g., double-trigger change-in-control, vesting cap on TSR awards if absolute TSR negative, addition of an absolute net income margin metric). Management argues that these features align executives with shareholder outcomes while managing risk via caps and clawback policies. A FOR vote supports management’s view that the program is appropriately structured and responsive to shareholder feedback; an AGAINST vote signals investor dissatisfaction and could prompt further changes. The vote is not binding, but the committee will consider the result when shaping future pay policies.
Approve amendment to eliminate Class B-1 shareholders' right to elect three directors and provide cash consideration ($6,200 per Class B-1 share) upon surrender.
This management proposal seeks shareholder approval to amend the certificate of incorporation to eliminate the Class B-1 shareholders’ statutory right to elect three directors beginning at the 2027 annual meeting, and to implement conforming bylaw changes. The board argues the Class B-1 process has failed to produce valid elections due to chronically low quorum/voter participation, leaving Class B directors as long-standing 'holdovers' and impeding board refreshment and governance flexibility. Management proposes $6,200 cash per Class B-1 share (625 total shares) as consideration upon surrender of the election rights. The board frames this as modernization to align governance with market practice while preserving member representation through nominations; it points to continued avenues to include market participants on the full slate of Equity directors. The proposal raises key governance tradeoffs: eliminating guaranteed member-elected seats centralizes director selection and can enhance board agility and independence, but also removes a structural safeguard for direct market participant representation. The cash payment likely reflects negotiated valuation of the election rights; tax treatment is noted as generally taxable to recipients. Approval requires both a “for” vote of a majority of outstanding Class B-1 shares and a majority of Class A and Class B shares voting together, and abstentions/broker non-votes count as against. The board recommends FOR, arguing benefits outweigh loss of structural Class B representation; opponents may focus on minority shareholder protections, preserving member influence, and adequacy of the payment.
Approve amendment to eliminate Class B-2 shareholders' right to elect two directors and provide cash consideration ($4,100 per Class B-2 share) upon surrender.
This management proposal seeks shareholder approval to amend the certificate of incorporation to eliminate the Class B-2 shareholders’ right to elect two directors beginning at the 2027 annual meeting, with $4,100 cash per Class B-2 share (813 total shares) as consideration. The board's rationale mirrors Item 4: chronic low voting participation has prevented valid Class B elections, creating holdover directors and hampering board refreshment and governance agility. The company argues elimination modernizes governance, aligns with investor expectations, and retains market-participant expertise via nominating processes. The proposal implicates governance and fairness issues: removing guaranteed Class B seats centralizes nomination authority and could enhance board flexibility and independence, but reduces member-elected safeguards. Vote thresholds require both a majority of the Class B-2 shares and a majority of Class A and Class B voting together; abstentions and broker non-votes count as votes against the amendment. The board recommends FOR, while opponents may highlight the loss of structural member influence and question the adequacy of cash consideration.
Approve amendment to eliminate Class B-3 shareholders' right to elect one director and provide cash consideration ($2,000 per Class B-3 share) upon surrender.
This management proposal seeks shareholder approval to amend the certificate of incorporation to eliminate the Class B-3 shareholders’ right to elect one director beginning at the 2027 annual meeting, with $2,000 cash per Class B-3 share (1,287 total shares) as consideration. The board's rationale is consistent with Items 4 and 5: the Class B-3 election process has seen low voter participation, leading to holdover directors and constraint on board composition and refreshment. Eliminating the right is presented as a modernization consistent with best practices and investor feedback while offering cash compensation to affected Class B holders. Governance tradeoffs are similar: the company gains flexibility and potentially improved governance, but Class B shareholders lose an institutional mechanism to guarantee direct representation of market participants. The proposal requires a majority vote of the Class B-3 shares and also a majority of Class A and Class B voting together; abstentions and broker non-votes count as against. The board recommends FOR; critics may question member representation and sufficiency of compensation.
If Items 4–6 are approved, approve conforming amendments to remove provisions that would be inoperative after eliminating Class B election rights.
This management proposal requests shareholder approval to amend the certificate of incorporation to remove or clarify provisions that would be inoperative if Items 4–6 are approved and filed. It is purely conforming and contingent upon approval of the Class B Election Rights amendments. The board frames the amendment as a technical housekeeping measure to implement the intended corporate governance modernization. The proposal only requires a majority vote of Class A and Class B shareholders voting together and will not be filed or implemented unless all of Items 4–6 pass. The board recommends FOR to ensure legal clarity and consistency following the substantive charter amendments.
Elect three Class B-1 directors, one Class B-2 director and one Class B-3 director to serve until the 2027 annual meeting.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 6.4% | 23,367,282 | $6.9B |
| 2 | STATE STREET CORP | 4.4% | 16,055,287 | $4.7B |
| 3 | BlackRock, Inc. | 3.4% | 12,413,560 | $3.7B |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.5% | 9,029,289 | $2.7B |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 7,972,902 | $2.4B |
| 6 | JPMORGAN CHASE CO | 2.2% | 7,965,314 | $2.4B |
| 7 | BlackRock, Inc. | 2.1% | 7,649,887 | $2.3B |
| 8 | Capital World Investors | 1.9% | 6,936,488 | $2.0B |
| 9 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.2% | 4,278,597 | $1.3B |
| 10 | Sanders Capital, LLC | 1.1% | 4,161,190 | $1.2B |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.